Research Article| Volume 21, ISSUE 12, P1155-1166, October 1986

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly

      This paper is only available as a PDF. To read, Please Download here.


      This comprehensive study investigated both the role of antidepressant drugs in the treatment of affective disorders of later life and their safety with careful clinical and pharmacological monitoring. A 7-week double-blind comparison was made of the efficacy and safety of nortriptyline (a tricyclic), phenelzine (a monoamine oxidase inhibitor), and placebo. The results indicated a response rate of approximately 60% for both nortriptyline and phenelzine versus a 13% response rate for placebo. Anticholinergic side effects were more frequently reported in the nortriptyline group. Orthostatic symptoms were reported with similar frequency in both drug groups. Overall, both drugs were well tolerated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Asberg M
        • Cronholm B
        • Sjoqvist F
        • Tuck D
        Relationship between plasma level and therapeutic effect of nortriptyline.
        Br Med J. 1971; 3: 331-334
        • Ashford JW
        • Ford VC
        Use of MAO inhibitors in elderly patients.
        Am J Psychiatry. 1979; 136: 1466-1467
        • Blazer D
        • Williams CD
        Epidemiology of dysphoria and depression in an elderly population.
        Am J Psychiatry. 1980; 137: 439-444
        • Georgotas A
        Affective disorders in the elderly: Diagnostic and research considerations.
        Age Ageing. 1983; 12: 1-10
        • Georgotas A
        • Mann J
        • Friedman E
        Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOIs in geriatric depression.
        Biol Psychiatry. 1981; 16: 997-1001
        • Georgotas A
        • Cooper T
        • Kim M
        • Hapworth W
        The treatment of affective disorders in the elderly.
        Psychopharmacol Bull. 1983; 19: 226-237
        • Georgotas A
        • Friedman E
        • McCarthy M
        • Mann J
        • Krakowski M
        • Siegel R
        • Ferris S
        Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
        Biol Psychiatry. 1983; 18: 195-205
        • Gurland B
        The epidemiology of depression and dementia in the elderly: The use of multiple indicators of these conditions.
        in: Cole Barrett Psychopathology in the Aged. Raven Press, New York1980: 37-60
        • Jarvik LS
        • Gerson S
        Outcome of drug treatment in depressed patients over the age of fifty.
        in: Shamoian Treatment of Affective Disorders in the elderly. APA Press, Washington, DC1985: 29-36
        • Kragh-Sørensen P
        • Asberg M
        • Christian EH
        Plasma-nortriptyline levels in endogenous depression.
        Lancet. 1973; i: 113-115
        • Montgomery SA
        • Braithwaite R
        • Dawling S
        • McAuley R
        High plasma nortriptyline levels in the treatment of depression.
        Clin Pharmacol Ther. 1978; 23: 309-314
        • Nies A
        • Robinson DS
        Monoamine oxidase inhibitors.
        in: Handbook of Affective Disorders. Churchill Livingstone, Edinburgh1980
        • Nies A
        • Robinson DS
        • Friedman MJ
        • Green R
        • Cooper TB
        • Ravaris CL
        • Ives JO
        Relationship between age and tricyclic antidepressant plasma levels.
        Am J Psychiatry. 1977; 134: 790-793
        • Raskin A
        Adverse reactions to phenelzine: Results of a nine-hospital depression study.
        J Clin Pharmacol. 1972; 12: 22-25
        • Reisberg B
        • Ferris SH
        • de Leon MJ
        • Crook T
        The global deterioration scale for assessment of primary degenerative dementia.
        Am J Psychiatry. 1982; 139: 1136-1139
        • Robinson DS
        Age-related factors affecting antidepressant drug metabolism and clinical response.
        in: Nancy K GeriatricPsychopharmacology. Elsevier-North Holland, New York1974
        • Robinson DS
        • Nies A
        • Ravaris L
        • Ives JO
        • Bartlett D
        Clinical pharmacology of phenelzine.
        Arch Gen Psychiatry. 1978; 35: 629-635
        • Roose S
        • Glassman AH
        • Siris S
        • et al.
        Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: A meaningful difference.
        J Clin Psychopharmacol. 1981; 1: 316-321
        • Sørensen B
        • Kragh-Sørensen P
        • Larsen NE
        • Hvidberg EF
        The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
        Psychopharmacology (Berl). 1978; 59: 35-39
        • Spitzer RD
        • Endicott J
        • Robins E
        Research Diagnostic Criteria. Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Walker JI
        • Cogington TR
        Diagnosis and pharmacological management of depression in the elderly.
        J Clin Exp Gerontol. 1982; 4: 1-39
        • Ziegler VE
        • Clayton PJ
        • Taylor JR
        • Co BT
        • Biggs JT
        Nortriptyline plasma levels and therapeutic response.
        Clin Pharmacol Ther. 1976; 20: 458-463